tiprankstipranks
IO Biotech (IOBT)
NASDAQ:IOBT
US Market

IO Biotech (IOBT) Income Statement

Compare
319 Followers

IO Biotech Income Statement

Last quarter (Q3 2024), IO Biotech's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, IO Biotech's net income was $-24.02M. See IO Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -756.00K$ -540.00K$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 91.44M$ 71.42M$ 41.23M$ 10.14M$ 9.91M
Depreciation and Amortization
$ 215.00K$ 540.00K$ 2.00K$ 10.14M$ 9.91M
EBITDA
$ -91.23M$ -69.34M$ -67.45M$ 0.00$ -824.00K
Operating Income
$ -91.44M$ -71.42M$ -41.23M$ -10.14M$ -9.91M
Other Income/Expenses
$ 6.21M$ 1.24M$ -26.58M$ -1.90M$ -830.00K
Pretax Income
$ -85.23M$ -70.19M$ -67.81M$ -12.04M$ -10.74M
Net Income
$ -86.08M$ -71.46M$ -67.88M$ -12.07M$ -10.75M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.98$ -2.48$ -2.36$ -0.42$ -0.37
Diluted EPS
$ -1.98$ -2.48$ -2.36$ -0.42$ -0.37
Weighted Average Shares Outstanding
43.54M 28.82M 28.82M 28.82M 28.82M
Weighted Average Shares Outstanding (Diluted)
43.54M 28.82M 28.82M 28.82M 28.82M
Currency in USD

IO Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis